Biodesix (BDSX) Net Cash Flow (2019 - 2026)

Biodesix (BDSX) has reported Net Cash Flow for 8 consecutive years, with $6.6 million the latest figure, recorded in Q1 2026.

• Net Cash Flow for Q1 2026 came in at $6.6 million, up 176.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.0 million (up 30.4% YoY), and the FY2025 annual result was -$7.3 million, down 18507.69% from the prior year.
• Net Cash Flow was $6.6 million for Q1 2026 at Biodesix, up from $2.4 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $30.7 million in Q2 2024 and troughed at -$17.8 million in Q1 2023.
• Average Net Cash Flow over 5 years is -$419882.4, with a median of -$4.1 million recorded in 2025.
• Year-over-year, Net Cash Flow soared 1092.06% in 2022 and sank 544.8% in 2024.
• Over 5 years, Net Cash Flow stood at $27.9 million in 2022, then plunged by 76.91% to $6.4 million in 2023, then plunged by 180.09% to -$5.2 million in 2024, then surged by 146.17% to $2.4 million in 2025, then surged by 176.33% to $6.6 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $6.6 million in Q1 2026, $2.4 million in Q4 2025, and -$4.1 million in Q3 2025.